Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine

Haematologica. 2022 Apr 1;107(4):1008-1010. doi: 10.3324/haematol.2021.279535.
No abstract available

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Purpura, Thrombotic Thrombocytopenic* / diagnosis
  • Purpura, Thrombotic Thrombocytopenic* / etiology
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine